Teva- Pharmaceutical Industries Ltd. TEVA

NYS: TEVA | ISIN: US8816242098   15/01/2026
32,35 USD (-0,89%)
(-0,89%)   15/01/2026
Grafiek Teva- Pharmaceutical Industries Ltd. Grafiek Teva- Pharmaceutical Industries Ltd.
woensdag 28 januari 2026, 13:00
Kwartaalcijfers (4de kwartaal)

Teva- Pharmaceutical Industries Ltd. in het nieuws

14 januari 2026 · AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine · Persbericht

12 januari 2026 · Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation · Persbericht

11 januari 2026 · Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo · Persbericht

5 januari 2026 · Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference · Persbericht

24 december 2025 · S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive · Persbericht

19 december 2025 · Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea® · Persbericht

12 december 2025 · Teva Releases Q4 2025 Aide Memoire · Persbericht

12 december 2025 · Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026 · Persbericht

9 december 2025 · Teva Pharmaceuticals Submits New Drug Application to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults · Persbericht

26 november 2025 · Teva obtient les autorisations de la Commission européenne pour PONLIMSI® (dénosumab), biosimilaire de Prolia® et DEGEVMA® (dénosumab), biosimilaire de Xgeva® · Persbericht

Profiel Teva- Pharmaceutical Industries Ltd.

Fabricage van farmaceutische preparaten
Farmaceutische Producten: Generisch
Gezondheidstechnologie
Productie

Mijn selecties